| Literature DB >> 24039693 |
Polina V Oliferenko1, Alexander A Oliferenko, Gennadiy I Poda, Dmitry I Osolodkin, Girinath G Pillai, Ulrich R Bernier, Maia Tsikolia, Natasha M Agramonte, Gary G Clark, Kenneth J Linthicum, Alan R Katritzky.
Abstract
Molecular field topology analysis, scaffold hopping, and molecular docking were used as complementary computational tools for the design of repellents for Aedes aegypti, the insect vector for yellow fever, chikungunya, and dengue fever. A large number of analogues were evaluated by virtual screening with Glide molecular docking software. This produced several dozen hits that were either synthesized or procured from commercial sources. Analysis of these compounds by a repellent bioassay resulted in a few highly active chemicals (in terms of minimum effective dosage) as viable candidates for further hit-to-lead and lead optimization effort.Entities:
Mesh:
Substances:
Year: 2013 PMID: 24039693 PMCID: PMC3765160 DOI: 10.1371/journal.pone.0064547
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Various synthetic and natural insect repellents and attractants.
Figure 2Chemical structures of 43 carboxamides.
The most active compounds, with MED < 0.150 µmol/cm2, are marked with squares; the least active compounds, with MED > 5 µmol/cm2, are marked with circles.
Experimental and predicted by the MFTA model Ae. aegypti repellency for 43 carboxamides and DEET[ ].
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
|
| 0.117 | 0.147 |
| (E)- | 0.625 | 0.600 |
|
|
| 0.156 | 0.160 |
|
| 0.625 | 0.257 |
|
|
| 0.195 | 0.290 |
|
| 0.172 | 0.211 |
|
|
| 0.104 | 0.132 |
|
| 0.156 | 0.176 |
|
|
| 0.125 | 0.155 |
|
| 0.145 | 0.093 |
|
|
| 0.375 | 0.306 |
|
| 5.160 | 7.012 |
|
|
| 0.125 | 0.164 |
|
| 0.172 | 0.127 |
|
|
| 0.406 | 0.305 |
| (E)- | 0.140 | 0.153 |
|
|
| 0.286 | 0.260 |
| Hexahydro-1-(1-oxohexyl)-1 | 0.033 | 0.108 |
|
|
| 0.469 | 0.512 |
| 1-(1-azepanyl)-2-methyl-1-pentanone | 0.102 | 0.089 |
|
| 1-(1-azepanyl)-2,2-dimethyl-1-propanone | 0.313 | 0.284 |
| (E)-1-(1-azepanyl)-2-methyl-2-penten-1-one | 0.098 | 0.089 |
|
| (E)- | 0.117 | 0.119 |
| hexahydro-1-(3-methylcrotonoyl)-1 | 0.140 | 0.109 |
|
| (E)- | 0.182 | 0.234 |
|
| 10.750 | 15.268 |
|
| (E)-2-methyl- | 0.417 | 0.216 |
|
| 20.125 | 28.443 |
|
|
| 0.192 | 0.145 |
|
| 20.250 | 24.890 |
|
|
| 0.313 | 0.285 |
|
| 20.500 | 24.830 |
|
|
| 0.219 | 0.269 |
| 3-cyclohexyl-N-methyl-N-octylpropanamide | 25.000 | 31.596 |
|
| (E)- | 0.274 | 0.322 |
| 4-methyl-N-phenylbenzamide | 25.000 | 14.768 |
|
| (E)- | 0.651 | 0.414 |
| 2-methyl-N-phenylbenzamide | 25.000 | 17.736 |
|
|
| 0.182 | 0.203 |
| N-cyclohexyl-N-isopropyl-4-methyloctanamide | 25.000 | 28.247 |
|
| (E) | 0.125 | 0.195 |
| N,N-dicyclohexyl-4-methyloctanamide | 25.000 | 20.564 |
|
|
| 0.266 | 0.205 |
| N,N-diethyl-3-methylbenzamide | 0.052 | 0.053 |
MED stands for the minimum effective dosage, µmol/cm2
Experimental and predicted by the MFTA model repellency for 27 assorted compounds.
|
|
|
|
|
|
|
|
|
|---|---|---|---|---|---|---|---|
|
| 2-methyl-4-nitro-3-nonanol | 0.047 | 0.043 |
| 2-phenyl-cyclohexanol | 0.047 | 0.058 |
|
| dibutyl fumarate | 0.047 | 0.036 |
| 1,2,3,4-tetrahydro-2-naphthol | 0.062 | 0.078 |
|
| 2-hydroxyethyl 2-hydroxybenzoate | 2.500 | 2.716 |
| 2-(2-bromophenyl)-1,3-dioxolane | 0.156 | 0.169 |
|
| 2-chlorophenethyl alcohol | 0.101 | 0.078 |
| (2-iodophenyl)methanol | 0.070 | 0.066 |
|
| 2-bromophenethyl alcohol | 0.049 | 0.076 |
| 2-nonanone | 0.437 | 0.285 |
|
| 2-ethyl-1-hexanol | 1.875 | 1.351 |
| 2-undecanone | 0.109 | 0.086 |
|
| 2-anilinoethanol | 1.875 | 0.679 |
| valencene | 0.138 | 0.157 |
|
| 3-phenyl-1-propanol | 0.406 | 0.531 |
| methyl salicylate | 0.312 | 0.278 |
|
| 1,2-pentanediol | 2.500 | 2.458 |
| carvacrol | 0.013 | 0.013 |
|
| 1,2,3,4-tetrahydro-1-naphthol | 0.078 | 0.068 |
| benzyl benzoate | 0.023 | 0.071 |
|
| 2-phenoxyethanol | 0.563 | 0.578 |
| thymol | 0.031 | 0.050 |
|
| 2-(N-ethylanilino)-ethanol | 0.156 | 0.113 |
| carvacrol methyl ether | 0.063 | 0.050 |
|
| 2-( | 0.219 | 0.240 |
| 2-nonanol | 0.066 | 0.084 |
|
| 2-cyclohexyl-cyclohexanol | 0.437 | 0.513 |
Figure 4MFTA model: (a) molecular super-graph, (b) factor dynamics, and (c) fit plot.
(a) The molecular supergraph is shown with two superimposed structures: DEET and N-cyclohexyl-N-ethyl-3-methylbutanamide (5m). The manner in which structures appear on MSG depends on how they can be superimposed onto the MSG as a whole. (b) The plot displays the change in correlation coefficient (R) and squared cross-validation coefficient (Q2) change as the number of factors changes. The best model is the one with the minimum possible number of factors and with R and Q2 at their highest values.
Figure 5Visualization of relative contributions of molecular fields to the title activity.
Positions discussed in the text are marked with arrows and boxed numbers; the six-membered ring (vertices 7 and 90-94) is encircled for clarity.
Descriptor values for selected positions of the supergraph.
| Position | Atom | Q | vdW | Lipo | Position | Atom | Q | vdW | Lipo | HBa | HBd |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2 | C(-CH2-) | -0.0377 | 1.7 | -0.3998 | 51 |
|
| ||||
|
|
|
|
| C(≡CH) | 0.3 | ||||||
| v. | 0 | 0 | -0.25 | 52 |
|
| |||||
| 50 |
|
|
| O(-OH) | 1.2 | ||||||
| C(-CH3) | 1.7 | -0.633 | 86 | C(-CH2-) | -0.0377 | 1.7 | -0.6327 | ||||
| 57 | C(-CH2-) | -0.0334 | -0.3998 |
| -0.0428 | 1.7 | -0.3998 | ||||
|
|
|
|
|
|
|
|
Most favourable atom types in terms of descriptor values are marked with bold (v. stands for vacancy)
Figure 62D predicted binding mode diagram for YF24 ((1S,2S)-2-phenylcyclohexanol).
2D protein-ligand interaction diagram generated using the Ligand Interaction script in Maestro (Schrödinger Inc., ). It outlines a highly hydrophobic cavity consisted of a number of proximate hydrophobic residues (shown in green circles) where YF24 binds. YF24 is represented as a 2D chemical sketch. A hydrogen bond between the ligand and Phe123 is shown by an arrow.
Comparison of best SP Glide docking results with experimental MED.
|
|
|
|
|---|---|---|
| YF23 | 0.625 | -8.520 |
|
| 0.039 | -8.491 |
| C40 | 25.00 | -8.367 |
|
| 0.065 | -8.363 |
| 5i' | 20.500 | -8.334 |
| 5w | 5.160 | -8.273 |
|
| 0.078 | -8.210 |
| C41 | 25.00 | -7.640 |
|
| 0.102 | -7.508 |
|
| 0.140 | -7.394 |
|
| 0.208 | -7.226 |
| 5d' | 20.250 | -7.222 |
|
| 0.172 | -7.203 |
| 5b' | 10.750 | -7.019 |
| 5f | 0.625 | -6.944 |
Comparison of Glide SP scoring, MFTA predicted MED values, and bioassay results for selected compounds.
| Compound | Glide score | MEDpred | MEDobs |
|---|---|---|---|
| X1 | -9.109 | 0.307 | >2.5[ |
| X2 | -8.166 | - | >2.5 |
| X4 | -8.715 | 0.030 | 0.078 |
| X5 | -8.643 | 0.067 | 0.156 |
| X7 | -7.797 | 0.112 | 0.417 |
| X8 | - | - | >2.5 |
| X9 | -8.106 | 0.182 | >2.5 |
| X10 | - | 0.330 | 1.25 |
| X11 | -7.910 | - | >2.5 |
| X12 | -7.757 | 0.096 | >2.5 |
| X14 | -6.684 | - | >2.5 |
| X15 | - | - | >2.5 |
| X16 | -8.405 | 0.303 | 0.261 |
| X17 | - | 0.082 | 1.667 |
| X18 | - | 0.219 | >2.5 |
| X19 | - | - | >2.5 |
| X20 | -7.666 | - | >2.5 |
| X21 | -7.529 | 2.786 | >2.5 |
| X23 | -6.832 | 0.061 | 0.039 |
| X24 | - | 0.036 | >2.5 |
| X25 | - | 0.198 | 1.87 |
| X26 | - | 0.010 | >2.5 |
| X27 | - | - | >2.5 |
repellent activity was not observed at the highest dosage of 2.5 µg/cm2
Figure 8Chemical structures of test set compounds.